TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2026
Back to search
Official data from USPTO
MOBILE PATH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MOBILE PATH
ST13
US500000088276625Class
1, 5, 10, 44
Filing
88276625
Registration
6859760
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
03/05/2026
Trademark type
Word
Nice classes
1, 5, 10, 44
Filing date
01/25/2019
Registration date
09/27/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/27/2022
Last transaction
03/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/21/2022
First use in commerce
07/21/2022
Drawing code
4
Owner type
03
Owner location
Monmouth Junction, NJ, US
Examiner
KON, ELISSA GARBER
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
E. C. (pessoa física)
Representatives
Xiongying Tu Schwabe, Williamson & Wyatt, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Assays for research purposes; Biological and chemical reagents used for non-medical purposesin vitro and in vivo scientific usethe testing of bodily fluidsthe detecting and analyzing of cellsproteinssmall moleculesnucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acidsDNA and RNA in a sample
Class 5
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cellsproteinssmall moleculesnucleotidesnucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detectioncancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseases; Diagnostic biomarker reagents for medical purposes
Class 10
Medical diagnostic apparatus for testing cellstissuebiomoleculesproteinssmall moleculesnucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic usemedical apparatus for diagnostic testing of health conditionsdiseasesabnormalities in the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesendocrine diseasesother tissue-based diagnostic testingcytologycell based testing; Medical apparatusdevicesinstruments for wellness testinghealth condition testinghealthcare testingpoint-of-care diagnostic devicesat-home diagnostic devicesportable health monitoring devices that detect health conditions and diseases in the nature of cancersblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseases and genetic diseases; Medical apparatusdevicesinstruments for the detection and identification of nucleic acidsDNA and RNA in a sample
Class 44
Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services in the field of digital healthcare services; Diagnostic servicesmedical testing for diagnostic purposes; Wellness servicesproviding wellness information; Medical servicesmedical assistancemedical consultationsmedical counselingmedical informationhealthcare testingdiagnostic testingwellness servicesall in the fields of cancerblood abnormalitiesimmune diseasesneurological diseasescardiovascular diseasesinfectious diseasesviral diseasesgenetic diseasesother tissue- based diagnostic testingcytologycell-based testing; Medical testing services for the detection and identification of cellsproteinssmall moleculesnucleic acids in a sample
Publications
History of USPTO decisions and trademark events.
48 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/27/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/27/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/20/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/19/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/09/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/09/2022
IUAF
USE AMENDMENT FILED
07/21/2022
EISU
TEAS STATEMENT OF USE RECEIVED
07/21/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/22/2022
EX4G
SOU EXTENSION 4 GRANTED
01/20/2022
EXT4
SOU EXTENSION 4 FILED
01/20/2022
EEXT
SOU TEAS EXTENSION RECEIVED
01/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/23/2021
EX3G
SOU EXTENSION 3 GRANTED
07/21/2021
EXT3
SOU EXTENSION 3 FILED
07/21/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/21/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/19/2021
EX2G
SOU EXTENSION 2 GRANTED
01/15/2021
EXT2
SOU EXTENSION 2 FILED
01/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2020
EX1G
SOU EXTENSION 1 GRANTED
07/09/2020
EXT1
SOU EXTENSION 1 FILED
07/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/09/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2019
PUBO
PUBLISHED FOR OPPOSITION
11/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/18/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/18/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/18/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2019
ALIE
ASSIGNED TO LIE
09/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2019
GNRT
NON-FINAL ACTION E-MAILED
03/22/2019
CNRT
NON-FINAL ACTION WRITTEN
03/22/2019
DOCK
ASSIGNED TO EXAMINER
03/22/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2019
NWAP
NEW APPLICATION ENTERED
01/29/2019
Continuous trademark protection
Get notified about every new filing that threatens MOBILE PATH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.